On the other hand, suppressors of viral transcription, such as TARDBP, which inhibits viral transcription by binding to the HIV-1 TAR element (32), were increased (1.7-fold) in latent infection (Fig. 4F). Here, TARDBP is linked to disease arising from reactivation of latent virus.